|
Device
|
Applicant
|
PMA Number
|
Decision Date
|
Cobas AmpliPrep and Cobas TaqMan CMV Test
|
Roche Molecular Systems, Inc. |
P110037 S050 |
10/10/2019 |
COBAS AmpliPrep/COBAS TaqMan CMV Test
|
Roche Molecular Systems, Inc. |
P110037 S051 |
11/05/2019 |
Cobas AmpliPrep/Cobas TaqMan CMV Test
|
Roche Molecular Systems, Inc. |
P110037 S052 |
02/20/2020 |
COBAS AmpliPrep/COBAS TaqMan CMV Test
|
Roche Molecular Systems, Inc. |
P110037 S053 |
05/14/2020 |
COBAS AmpliPrep/COBAS TaqMan CMV Test
|
Roche Molecular Systems, Inc. |
P110037 S054 |
08/26/2020 |
COBAS AmpliPrep/COBAS TaqMan CMV Test
|
Roche Molecular Systems, Inc. |
P110037 S055 |
03/09/2021 |
COBAS AmpliPrep/COBAS TaqMan CMV Test
|
Roche Molecular Systems, Inc. |
P110037 S056 |
08/11/2021 |
COBAS® AmpliPrep/ COBAS® TaqMan® CMV Test
|
Roche Molecular Systems, Inc. |
P110037 S057 |
11/14/2022 |
COBAS® AmpliPrep, COBAS® TaqMan® CMV Test
|
Roche Molecular Systems, Inc. |
P110037 S058 |
08/17/2023 |
COBAS® AmpliPrep/COBAS® TaqMan® CMV Test
|
Roche Molecular Systems, Inc. |
P110037 S059 |
08/23/2023 |